Literature DB >> 6350379

Coexisting lichen planus and bullous pemphigoid or lichen planus pemphigoides?

P G Lang, J C Maize.   

Abstract

A patient with lichen planus pemphigoides is reported. Initial pathologic and immunopathologic evaluation was consistent with coexisting bullous pemphigoid and lichen planus. However, further immunologic evaluation suggested that the circulating antibody was not directed toward bullous pemphigoid antigen but another basement membrane zone antigen. This finding indicates a need for immunologic re-evaluation of lichen planus pemphigoides.

Entities:  

Mesh:

Year:  1983        PMID: 6350379     DOI: 10.1016/s0190-9622(83)70119-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Ultrastructural localization of the binding sites of antibasement membrane zone antibodies in lichen planus pemphigoides on 1.0 M sodium chloride-separated skin.

Authors:  S Ikeda; Y Song; H Yaguchi; K Naito; S Morioka; H Ogawa; T Muramatsu
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

3.  Treatment of lichen planus pemphigoides with mesalamine: novel use of this drug.

Authors:  Vijay Gandhi; Pradeep Kumar; Ankita Chauhan
Journal:  An Bras Dermatol       Date:  2022-09-06       Impact factor: 2.113

4.  Atypical clinical presentation of lichen planus bullous in a systemic sclerosis patient.

Authors:  Zofia A Gerlicz-Kowalczuk; Jolanta D Torzecka; Marek Kot; Bożena Dziankowska-Bartkowiak
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

Review 5.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.